DK0642792T3 - Stabile opløsninger af platin(II)-antitumormidler - Google Patents

Stabile opløsninger af platin(II)-antitumormidler

Info

Publication number
DK0642792T3
DK0642792T3 DK94112519.7T DK94112519T DK0642792T3 DK 0642792 T3 DK0642792 T3 DK 0642792T3 DK 94112519 T DK94112519 T DK 94112519T DK 0642792 T3 DK0642792 T3 DK 0642792T3
Authority
DK
Denmark
Prior art keywords
platinum
antitumor agents
stable solutions
solutions
oxygen
Prior art date
Application number
DK94112519.7T
Other languages
English (en)
Inventor
Murray A Kaplan
Robert K Perrone
Lawan Phusanti
Scott R Stenberg
Sheeram Agharkar
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22307943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0642792(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0642792T3 publication Critical patent/DK0642792T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
DK94112519.7T 1993-08-11 1994-08-10 Stabile opløsninger af platin(II)-antitumormidler DK0642792T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/105,817 US5455270A (en) 1993-08-11 1993-08-11 Stabilized solutions of platinum(II) antitumor agents

Publications (1)

Publication Number Publication Date
DK0642792T3 true DK0642792T3 (da) 1997-10-20

Family

ID=22307943

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94112519.7T DK0642792T3 (da) 1993-08-11 1994-08-10 Stabile opløsninger af platin(II)-antitumormidler

Country Status (24)

Country Link
US (1) US5455270A (da)
EP (1) EP0642792B1 (da)
JP (1) JP3629044B2 (da)
KR (1) KR100351713B1 (da)
CN (1) CN1082813C (da)
AT (1) ATE152349T1 (da)
AU (1) AU685126B2 (da)
CA (1) CA2128641A1 (da)
CY (1) CY2021A (da)
CZ (1) CZ188494A3 (da)
DE (1) DE69402931T2 (da)
DK (1) DK0642792T3 (da)
ES (1) ES2102743T3 (da)
FI (1) FI113618B (da)
GR (1) GR3024340T3 (da)
HK (1) HK115497A (da)
HU (1) HU220074B (da)
IL (1) IL110577A (da)
NO (1) NO308288B1 (da)
NZ (1) NZ264210A (da)
PL (1) PL178689B1 (da)
RU (1) RU2142797C1 (da)
TW (1) TW383224B (da)
ZA (1) ZA946007B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE197249T1 (de) * 1994-08-08 2000-11-15 Debiopharm Sa Stabiles arzneimittel enthaltend oxaliplatin
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
DK2255800T3 (da) * 1997-11-10 2013-02-04 Sloan Kettering Inst Cancer Arsentrioxid til anvendelse ved behandling af leukæmi
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
UA71985C2 (uk) * 1999-08-30 2005-01-17 Дебіофарм С.А. Стабільний фармацевтичний препарат оксаліплатини для парентерального введення та спосіб його одержання
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CN1121380C (zh) 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
DE10032256C2 (de) * 2000-07-03 2003-06-05 Infineon Technologies Ag Chip-ID-Register-Anordnung
KR100363394B1 (ko) * 2000-08-21 2002-12-05 한국과학기술연구원 온도감응성을 갖는 포스파젠삼량체-백금착물 복합체, 그의제조방법 및 그를 함유하는 항암제 조성물
ATE431352T1 (de) * 2001-11-30 2009-05-15 Jingzun Wang Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
FR2841784B1 (fr) * 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
EP1879568B1 (en) * 2005-03-28 2009-05-06 Dabur Pharma Limited Stable pharmaceutical compositions of platinum (ii) antitumour agents
US20090182043A1 (en) * 2005-12-29 2009-07-16 Seiji Nishida Pharmaceutical Preparation of Aqueous Solution Containing Platinum Complex
CN101723982B (zh) * 2008-10-31 2013-01-02 齐鲁制药有限公司 具有抗癌活性的合铂化合物及其合成方法
EP3280408B1 (en) * 2015-04-10 2019-10-23 Syn-Nat Products Enterprise LLC Process for the preparation of dicycloplatin
WO2016187191A1 (en) * 2015-05-18 2016-11-24 Medoc Pharmaceutical Co., Ltd. A pharmaceutical co-crystal and use thereof
CN105726474B (zh) * 2016-04-12 2018-04-13 周英杰 一种用于治疗晚期卵巢癌的注射液及其制备方法
CN105726475B (zh) * 2016-04-12 2018-05-04 青岛市妇女儿童医院 一种治疗晚期卵巢癌的注射液及其制备方法
CN106188150A (zh) * 2016-04-13 2016-12-07 范如霖 一类碳铂复合物抗癌药及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (da) * 1972-06-08 1977-06-15 Research Corp
US4657927A (en) * 1978-05-04 1987-04-14 Research Corporation Malonato platinum compounds
CH672109A5 (da) * 1987-01-30 1989-10-31 Wiedmer Plastikform W
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
IL85790A0 (en) * 1988-03-20 1988-09-30 Abic Ltd Solution of carboplatin
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.

Also Published As

Publication number Publication date
AU6898294A (en) 1995-02-23
JPH0753368A (ja) 1995-02-28
HUT75154A (en) 1997-04-28
DE69402931D1 (de) 1997-06-05
CY2021A (en) 1998-02-20
ATE152349T1 (de) 1997-05-15
DE69402931T2 (de) 1997-12-18
NZ264210A (en) 1995-10-26
ES2102743T3 (es) 1997-08-01
IL110577A0 (en) 1994-11-11
TW383224B (en) 2000-03-01
HU220074B (hu) 2001-10-28
RU94028650A (ru) 1996-11-10
NO942944L (no) 1995-02-13
HU9402307D0 (en) 1994-10-28
GR3024340T3 (en) 1997-10-31
RU2142797C1 (ru) 1999-12-20
ZA946007B (en) 1995-02-10
CZ188494A3 (en) 1995-02-15
FI943666A0 (fi) 1994-08-08
CA2128641A1 (en) 1995-02-12
JP3629044B2 (ja) 2005-03-16
KR100351713B1 (ko) 2002-12-28
PL178689B1 (pl) 2000-06-30
KR950005305A (ko) 1995-03-20
US5455270A (en) 1995-10-03
HK115497A (en) 1997-08-29
AU685126B2 (en) 1998-01-15
CN1118252A (zh) 1996-03-13
EP0642792A1 (en) 1995-03-15
CN1082813C (zh) 2002-04-17
IL110577A (en) 2000-06-01
EP0642792B1 (en) 1997-05-02
FI943666A (fi) 1995-02-12
PL304601A1 (en) 1995-02-20
FI113618B (fi) 2004-05-31
NO942944D0 (no) 1994-08-09
NO308288B1 (no) 2000-08-28

Similar Documents

Publication Publication Date Title
DK0642792T3 (da) Stabile opløsninger af platin(II)-antitumormidler
BE2014C061I2 (da)
FI951190A0 (fi) Menetelmä pranoprofeenin stabilisoimiseksi ja pranoprofeenin stabiili nestemäinen valmiste
EP1069121A4 (en) REAGENT FOR DETECTING SINGULET OXYGEN
ATE275177T1 (de) Tintenzusammensetzung enthaltend einen kupferkomplex-farbstoff
ES8800168A1 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
AU551841B2 (en) Diamide pest control agents
TR21241A (tr) 4 - halo - s*bstit*e edilmis sakaroz t*revleri
ATE210715T1 (de) Stabilisierung von nichthalogenierten 3- isothiazolonen in aggressiven systemen
EP1431347A4 (en) COMPOSITION CONTAINING FINE PARTICLES FOR CARRIERING BIOLOGICAL ACTIVE SUBSTANCES OR BIOLOGICAL ACTIVITIES BASED ON THEM, AND METHOD OF PRODUCTION THEREOF
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
ZA881430B (da)
EP0978281A4 (en) EYE DROPS
FI901873A0 (fi) Deaktivering av fosfoniumbiocider.
ATE163005T1 (de) Saintopin derivate
Fukuzumi et al. Blue transient complex formation in the electron–transfer reaction between iron (III) and a reduced nicotinamide–adenine dinucleotide analogue without an amide group
ES2040181B1 (es) Procedimiento para la obtencion de nuevas dihidropiridinas.
JP2000109305A (ja) 亜硫酸塩水溶液の安定化方法
TH3430EX (th) อาโซลิล-อารอกซีเมทธิล-ไดเมทธิล เพนตินอล
DE3682380D1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.
TH4615A (th) อนุพันธ์ต่าง ๆ ของเบนโซไธอะซิโนน
TH13251A (da)